Case Study: Hikma Pharmaceuticals achieves dual-audience engagement with Responsory

Hikma Pharmaceuticals drives 35% HCP engagement with Responsory

Hikma Pharmaceuticals faced the challenge of launching a digital resource for its rheumatoid arthritis drug, Ridaura®, which carries a black box warning. They needed a solution that would address patient concerns without compromising the clinical information required by healthcare professionals, all within a strict four-month timeline. The vendor, Responsory, was tasked with creating this multi-purpose educational hub.

Responsory implemented a dual-path digital strategy, creating a website with separate sections for patients and healthcare professionals. They also designed a companion brochure for sales reps. The solution was highly successful, with over 35% of visitors navigating to the HCP section and 26% engaging with patient resources. The entire project was delivered on its four-month schedule and was immediately praised by Hikma's sales team.

Hikma Pharmaceuticals